Bizarre Patents
Decorative Jeweled Wheel Cover
An improved wheel is provided wherein decorative items such as gem stones are embedded in either the wheel surface, a special mounting section attached to the wheel surface, or to a spoke strap that wraps around each spoke and positions embedded gem stones on the outside surface of the spoke.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20110200549 | Organic Compounds Suitable For Modulating Fragrance Compositions Disclosed are compounds having the ability to modulate, namely to improve, enhance and/or modify fragrance compositions due to their ability to inhibit cytochrome P450 enzymes, e.g. CYP2A, e.g. 2A13 and 2A6, and CYP2B6.... | 08/18/2011 |
| 20110105572 | CARBAMIC ACID COMPOUNDS COMPRISING AN AMIDE LINKAGE AS HDAC INHIBITORS This invention pertains to certain active carbamic acid compounds which inhibit HDAC activity and which have the following formula: wherein: A is a C5-20heteroaryl or C5-20carboaryl grou... | 05/05/2011 |
| 20110046128 | NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS A series of novel compounds showing anticonvulsant, chemical countermeasure(s), and analgesic activities is described. Such pharmaceutically active compounds may also show utility in the treatment of other central nervous system (“CNS”) diseases and disorders, such ... | 02/24/2011 |
| 20100305331 | ALPHA KETOAMIDE COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositi... | 12/02/2010 |
| 20100267780 | BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS Compounds of formula (I) or pharmaceutically acceptable salts thereof, are opioid receptor modulators, e.g. mu-opioid receptor antagonists, neutral antagonists or inverse agonists, and are useful inter alia for the treatment of obesity. ... | 10/21/2010 |
| 20100222593 | METHOD FOR PRODUCING 2,2-DIFLUOROETHYLAMINE DERIVATIVE BY AMIDE HYDROGENATION Process for preparing 2,2-difluoroethylamine derivatives, wherein compounds of the general formula (IV) are reduced to the corresponding 2,2-difluoroethylamine derivatives of the general formula (III), where the A radical is as defined in the description: 09/02/2010 | |
| 20100203650 | BIOMOLECULE BINDING LIGANDS The invention provides biomolecule binding ligands, collections of biomolecule binding ligands, and their use in the purification of biological mixtures and in the identification of ligands having an affinity for a substance. The ligand is a compound of formula (III) or... | 08/12/2010 |
| 20100140561 | CARBON NANOTUBE N-DOPING MATERIAL, CARBON NANOTUBE N-DOPING METHOD AND DEVICE USING THE SAME Nicotinamide and/or a compound which is chemically combined with nicotinamide may be used as a carbon nanotube (“CNT”) n-doping material. CNTs n-doped with the CNT n-doping material may have long-lasting doping stability in the air without de-doping. Further, CNT n-... | 06/10/2010 |
| 20100068553 | ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, METHOD OF MANUFACTURE AND USE IN WATCHMAKING AS AN EPILAME The invention relates to a novel ultra-thin hydrophobic and oleophobic layer, formed by self-assembly on a solid substrate surface, of compounds of the general formula
| 03/18/2010 |
| 20100056783 | Novel Process for the Preparation of Statins and their Pharmaceutically Acceptable Salts thereof Novel process for the preparation of statins and their pharmaceutically acceptable salts thereof represented by the general formula-(1) through novel intermediate compounds of general formula-(4). ... | 03/04/2010 |
| 20100048647 | NEMATICIDAL AGENT COMPOSITION AND METHOD OF USING THE SAME The present invention provides a nematocide containing, as an active ingredient, an N-2-(pyridyl)ethylcarboxamide derivative represented by the formula (I): wherein Ar is a substituted phenyl group having one... | 02/25/2010 |
| 20100035938 | Cooling Compounds A method of providing a cooling effect to a product includes the incorporation into the product of at least one compound of the formula I in which m is a number between 0 and 2, X, Y and Z are selected indepe... | 02/11/2010 |
| 20090163496 | ANTIBACTERIAL AGENTS Antibacterial compounds of formula I are provided: As well as stereoisomers, pharmaceutically acceptable salts, esters, and prodrugs thereof; pharmaceutical compositions comprising such compounds; methods of ... | 06/25/2009 |
| 20090136561 | Non-peptidyl agents with pHSP20-like activity, and uses thereof The present invention provides compositions and methods for modulating smooth muscle cells. The present invention also provides methods of identifying small molecule candidate therapeutic agents for modulating smooth muscle.... | 05/28/2009 |
| 20090111834 | NOVEL FLAVORS, FLAVOR MODIFIERS, TASTANTS, TASTE ENHANCERS, UMAMI OR SWEET TASTANTS, AND/OR ENHANCERS AND USE THEREOF The present invention relates to the discovery that certain non-naturally occurring, non-peptide amide compounds and amide derivatives, such as oxalamides, ureas, and acrylamides, are useful flavor or taste modifiers, such as a flavoring or flavoring agents and flavor o... | 04/30/2009 |
| 20090030042 | Amide Addition Reaction A method of making a compound of formula II comprising the reaction of a compound of formula RCONH2 with a compound of formula III R be... | 01/29/2009 |
| 20080255095 | Benzylamine analogues A compound of the formula (I): wherein R1 is C1-C6 alkyl, amino, (C1-C6 alkyl)amino, di(C1-C6 alkyl)amino or a nitrogen-containing ... | 10/16/2008 |
| 20080194536 | Cyanoarylamines The present invention relates to a compound represented by the following formula: (I) or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof, or a combination thereof,... | 08/14/2008 |
| 20080114176 | Process For The Preparation Of A 2-Ethylaminopyridine Derivative Process for the preparation of a 2-ethylaminopyridine derivative of general formula (I) or a salt thereof Process for the preparation of a N-[2-(2-pyridinyl)ethyl]carboxamide derivative of general formula (II... | 05/15/2008 |
| 20080039506 | Aminoalcohol Derivatives The present invention relates to a compound of the formula [I]: wherein (a), in which —Y—, R4, R5 and R6 are4 R5 each as defined in the description, etc., R1 is hydrogen, halogen, lower alkyl, hydroxy... | 02/14/2008 |
| 20070293501 | Thioalkeneamides as Transketolase Inhibitors The present invention provides thioalkeneamides of formula (I) which are useful as transketolase inhibitors: wherein R1, R2, R3, R4, R5, R6, Ra-Rd, n and ring A are as defined herein... | 12/20/2007 |
| 20070265268 | Hsp90 Family protein Inhibitors The present invention provides Hsp90 family protein inhibitors comprising, as an active ingredient, a benzoic acid derivative represented by General Formula (I): [wherein n represents an integer of 0 to 10; R1 represents substituted or unsubstituted... | 11/15/2007 |
| 20070259849 | Azine-Carboxamides as Anti-Cancer Agents The invention relates to chemical compounds, of the formula (I): or pharmaceutically acceptable salts thereof, which possess B-Raf inhibitory activity and are accordingly useful for their anti cancer activity and thus in methods of treatment of the human or animal body... | 11/08/2007 |
| 20070249620 | Urea Derivative The present invention relates to a urea derivative or a pharmacologically acceptable salt thereof having an excellent DGAT inhibitory effect. A urea derivative having the formula: [wherein R1 is a C6-C10 aryl group which may be... | 10/25/2007 |
| 20070219197 | Pyridyl alkene and pyridyl alkine- acid amides as cytostatics and immuno-suppressives The present invention relates to new pyridine compounds, methods for their production, medicaments containing these compounds as well as their use, especially in the treatment of tumor conditions and/or as cytostatic agents or as immunosuppressive agents. ... | 09/20/2007 |
| 20070213374 | Malonamide Derivatives The present invention relates to malonamide derivatives of formula A-D-B-1, as inhibitors of raf-kinase and the use of the compounds of formula (I) for the manufacture of a pharmaceutical composition. ... | 09/13/2007 |
| 20070208166 | Tao Kinase Modulators And Method Of Use The invention provides compounds and methods for inhibition of kinases, such as those of the TAO family, more specifically KIAA1361, TAO, and JIK kinases. The invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activitie... | 09/06/2007 |
| 20070203204 | 2-Pyridinylcycloalkylbenzamide Derivatives And Their Use As Fungicides A compound of general formula (I): A process for preparing this compound. A fungicidal composition comprising a compound of general formula (I). A method for treating plants by applying a compound of general formula (I) or a composition comprising it. ... | 08/30/2007 |
| 20070185116 | Bicyclic compounds The present invention is to provide a bicyclic compound represented by the following formula: wherein Ring Q is pyridine or pyrimidine; Ring A is benzene or a heterocyclic ring;
| |
| 20070185171 | Compounds and methods of use Selected compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for pr... | 08/09/2007 |
| 20070161685 | HETEROCYCLIC CETP INHIBITORS Compounds of formula Ia and Ib wherein A, B, C and R1 are described herein. ... | 07/12/2007 |
| 20070149525 | Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein. ... | 06/28/2007 |
| 20070135450 | Compounds and Methods of Treating Insulin Resistance and Cardiomyopathy Novel compounds, compositions comprising compounds, and methods for methods for preparing and using compounds are described herein. Methods of treating or ameliorating various conditions, including insulin resistance, pancreatic beta cell apoptosis, obesity, pro-thrombo... | 06/14/2007 |
| 20070135498 | Organic compounds Disclosed are δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amide compounds of formula (I) and the salts thereof, having renin-inhibiting properties. Also disclosed are pharmaceutical compositions comprising these compounds and methods of administering them for the trea... | 06/14/2007 |
| 20070123493 | Benzamide derivative To provide compounds which have high angiogenesis inhibiting activity, and are useful as agents for effective treatment and prevention of diseases involving pathologic angiogenesis, for example, cancer and cancer metastasis, methods for producing the compounds, intermed... | 05/31/2007 |
| 20070105860 | Biphenylcarboxylic Amide Derivatives as p38 Kinase Inhibitors Compounds of formula (I): or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors. ... | 05/10/2007 |
| 20070105859 | 4-Phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (mek) inhibitors A compound of the present invention, or a pharmaceutically acceptable salt thereof is indicated by formula (1) below: wherein, R1, R2, R3, R4, R5, R6, Q, R8, and R9 have th... | 05/10/2007 |
| 20070099965 | 2-Pyridinylethylbenzamide derivatives A compound of general formula (I): A process for preparing this compound. A fungicidal composition comprising a compound of general formula (I). A method for treating plants by applying a compound of general formula (I) or a composition comprising it. ... | 05/03/2007 |
| 20070088053 | Non-nucleoside reverse transcriptase inhibitors The present invention provides for compounds useful for treating an HIV-1 infection, or preventing an HIV-1 infection, or treating AIDS or ARC. The compounds of the invention are of formula I wherein R1-R4 and Ar are as herein defined. Also disclosed in the present inv... | 04/19/2007 |
| 20070060624 | Novel bioisosteres of actinonin The present invention relates to novel bioisosteres of the antibiotic actinonin of the general formula (I). The novel compounds are of particular interest as inhibitors of metalloproteinases. ... | 03/15/2007 |
